GLP-1 receptor agonists in patients with type 2 diabetes: cardiorenal protection versus ocular safety
Nephrology Dialysis Transplantation · 30.10.2026 · 41 (11) · 1931-1933
DOI: 10.1093/ndt/gfag131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 18.06.2026. Verfasst von Elisabeth Buur Stougaard und 1 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center Copenhagen, Department of Clinical Translational Research, Herlev, Denmark. Die Arbeit nennt 27 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Steno Diabetes Center Copenhagen, Department of Clinical Translational Research, Herlev, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Peter Rossing
Zitieren
APA
Stougaard, E. B., & Rossing, P. (2026). GLP-1 receptor agonists in patients with type 2 diabetes: cardiorenal protection versus ocular safety. Nephrology Dialysis Transplantation, 41(11), 1931-1933. https://doi.org/10.1093/ndt/gfag131
Vancouver
Stougaard EB, Rossing P. GLP-1 receptor agonists in patients with type 2 diabetes: cardiorenal protection versus ocular safety. Nephrology Dialysis Transplantation. 2026;41(11):1931-1933. doi:10.1093/ndt/gfag131
BibTeX
@article{Stougaard2026,
author = {Stougaard, Elisabeth Buur and Rossing, Peter},
title = {GLP-1 receptor agonists in patients with type 2 diabetes: cardiorenal protection versus ocular safety},
journal = {Nephrology Dialysis Transplantation},
year = {2026},
volume = {41},
number = {11},
pages = {1931--1933},
doi = {10.1093/ndt/gfag131}
}
EUVIMED